Financial Contrast: Rennova Health (OTCMKTS:RNVA) and Health Catalyst (NASDAQ:HCAT)

Rennova Health (OTCMKTS:RNVA) and Health Catalyst (NASDAQ:HCAT) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

Earnings and Valuation

This table compares Rennova Health and Health Catalyst”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rennova Health	$18.69 million	0.00	-$7.73 million	N/A	N/A
Health Catalyst	$316.06 million	0.52	-$69.50 million	($1.59)	-1.45

Rennova Health has higher earnings, but lower revenue than Health Catalyst.

Analyst Ratings

This is a summary of current ratings and price targets for Rennova Health and Health Catalyst, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rennova Health	0	0	0	0	0.00
Health Catalyst	1	8	5	0	2.29

Health Catalyst has a consensus target price of $4.36, suggesting a potential upside of 89.31%. Given Health Catalyst’s stronger consensus rating and higher possible upside, analysts clearly believe Health Catalyst is more favorable than Rennova Health.

Insider & Institutional Ownership

85.0% of Health Catalyst shares are held by institutional investors. 55.5% of Rennova Health shares are held by insiders. Comparatively, 2.6% of Health Catalyst shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Rennova Health and Health Catalyst’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Rennova Health	N/A	N/A	N/A
Health Catalyst	-34.05%	-6.67%	-3.21%

Volatility and Risk

Rennova Health has a beta of 22.6, indicating that its share price is 2,160% more volatile than the S&P 500. Comparatively, Health Catalyst has a beta of 1.69, indicating that its share price is 69% more volatile than the S&P 500.

Summary

Rennova Health beats Health Catalyst on 6 of the 11 factors compared between the two stocks.

About Rennova Health

Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. It owns one operating hospital in Oneida, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company is based in West Palm Beach, Florida.

About Health Catalyst

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.